drugset / Trial / NCT06907628
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SHR-3792 injection monotherapy for patients with advanced solid tumors, and to explore the reasonable dosage of SHR-3792 injection monotherapy for patients with advanced solid tumors.
Timeline
- Start
- 2025-04-02
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-3792 | Unknown | — | — |